Biohaven
Biohaven is a Connecticut-based pharmaceutical company that researches and develops novel drugs for the treatment of neurological and neuropsychiatric diseases.
Business Model:
Revenue: $859.7M
Employees: 501-1,000
Detailed Biohaven Information
Geographic Data
Address: 215 Church Street
City: New Haven
State: CT
Zip: 06510
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$200M
Raised Total:$444M
Social
Metrics
1,190,664Website Global Rank
25,689Website Monthly Traffic
Twitter Followers
Description
Biohaven is a Connecticut-based pharmaceutical company that researches and develops novel drugs for the treatment of neurological and neuropsychiatric diseases.
Contact Phone:
+12034040410
Contact Email:
Biohaven went public on 5/5/2017 on the NYSE
Listed Exchange:
NYSE
IPO Date:
5/5/2017
IPO Valuation:
$582M
Ticker Symbol:
BHVN
IPO Price:
$17/share
Amount Raised:
$168M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2018 | Kleo | Series B | 0 |
| 3/2021 | Artizan Biosciences | Series A | 0 |
| 9/2016 | Kleo | Series A | - |
| 3/2021 | Artizan Biosciences | Series A | 0 |
| 11/2018 | Kleo | Series B | 0 |
| 9/2016 | Kleo | Series A | - |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2022 | Post-IPO Equity | $301.9M | 8/2020 | Debt | $500M |
Sixth Street Partners |
5/2017 | IPO | $168.3M | 12/2018 | Post-IPO Equity | $143.7M | 6/2022 | Post-IPO Equity | 1 | - |
Soros Fund Management Soros Fund Management |
3/2017 | Venture Round | $20M | 3/2021 | Post-IPO Equity | $200M | 10/2016 | Equity | $80M |
Venrock RA Capital Management Vivo Capital Aisling Capital Rock Springs Capital Osage University Partners Aperture Venture Partners Connecticut Innovations |
11/2016 | Venture Round | 12 | $80M |
Venrock RA Capital Management Rock Springs Capital OUP (Osage University Partners) Aisling Capital Greg Bailey Knoll Capital Management Connecticut Innovations Litmore Capital John W. Childs Venrock Vivo Capital Venrock RA Capital Management Rock Springs Capital OUP (Osage University Partners) Aisling Capital Greg Bailey Knoll Capital Management Connecticut Innovations Litmore Capital John W. Childs Venrock |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2021 | Kleo |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
